S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
BAC   32.70 (-0.27%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
BAC   32.70 (-0.27%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
BAC   32.70 (-0.27%)
S&P 500   3,096.63 (+0.08%)
DOW   27,781.96 (-0.01%)
QQQ   201.43 (-0.08%)
CGC   15.84 (-14.38%)
BABA   182.80 (+0.18%)
GE   11.29 (+0.00%)
T   38.95 (-0.54%)
F   8.79 (-0.23%)
ACB   3.29 (-7.32%)
BAC   32.70 (-0.27%)
Log in

Petmed Express Stock Price, Forecast & Analysis (NASDAQ:PETS)

$22.33
-0.64 (-2.79 %)
(As of 11/14/2019 04:00 PM ET)
Today's Range
$22.18
Now: $22.33
$22.99
50-Day Range
$17.41
MA: $21.18
$27.45
52-Week Range
$15.00
Now: $22.33
$27.80
Volume29,782 shs
Average Volume1.27 million shs
Market Capitalization$450.40 million
P/E Ratio17.91
Dividend Yield4.68%
Beta0.63
PetMed Express, Inc and its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. It markets prescription and non-prescription pet medications, and other health products for dogs and cats directly to the consumers. The company offers non-prescription medications and supplies, including flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, such as heartworm preventative, flea and tick preventative, arthritis, thyroid, diabetes, pain, heart/blood pressure, and other specialty medications, as well as generic substitutes. Read More…

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryInternet Retail
SectorRetail/Wholesale
Current SymbolNASDAQ:PETS
CUSIP71638210
Phone561-526-4444

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$283.42 million
Cash Flow$1.87 per share
Book Value$6.22 per share

Profitability

Net Income$37.74 million

Miscellaneous

Employees187
Market Cap$450.40 million
Next Earnings Date1/28/2020 (Estimated)
OptionableOptionable

Receive PETS News and Ratings via Email

Sign-up to receive the latest news and ratings for PETS and its competitors with MarketBeat's FREE daily newsletter.


Petmed Express (NASDAQ:PETS) Frequently Asked Questions

What is Petmed Express' stock symbol?

Petmed Express trades on the NASDAQ under the ticker symbol "PETS."

How often does Petmed Express pay dividends? What is the dividend yield for Petmed Express?

Petmed Express declared a quarterly dividend on Monday, October 21st. Investors of record on Monday, November 4th will be given a dividend of $0.27 per share on Friday, November 15th. This represents a $1.08 annualized dividend and a yield of 4.84%. The ex-dividend date is Friday, November 1st. View Petmed Express' Dividend History.

How were Petmed Express' earnings last quarter?

Petmed Express Inc (NASDAQ:PETS) announced its quarterly earnings data on Monday, October, 21st. The company reported $0.33 earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of $0.26 by $0.07. The business earned $69.94 million during the quarter, compared to the consensus estimate of $69.65 million. Petmed Express had a net margin of 9.62% and a return on equity of 20.45%. Petmed Express's quarterly revenue was down 2.0% on a year-over-year basis. During the same quarter last year, the company earned $0.52 EPS. View Petmed Express' Earnings History.

When is Petmed Express' next earnings date?

Petmed Express is scheduled to release their next quarterly earnings announcement on Tuesday, January 28th 2020. View Earnings Estimates for Petmed Express.

What price target have analysts set for PETS?

1 brokerages have issued 1-year target prices for Petmed Express' stock. Their forecasts range from $20.00 to $20.00. On average, they anticipate Petmed Express' share price to reach $20.00 in the next year. This suggests that the stock has a possible downside of 10.4%. View Analyst Price Targets for Petmed Express.

What is the consensus analysts' recommendation for Petmed Express?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Petmed Express in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Petmed Express.

Has Petmed Express been receiving favorable news coverage?

News articles about PETS stock have trended somewhat negative this week, according to InfoTrie. The research firm rates the sentiment of press coverage by analyzing more than six thousand blog and news sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Petmed Express earned a coverage optimism score of -1.4 on InfoTrie's scale. They also gave news articles about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for Petmed Express.

Are investors shorting Petmed Express?

Petmed Express saw a decline in short interest in the month of October. As of October 15th, there was short interest totalling 8,130,000 shares, a decline of 5.2% from the September 15th total of 8,580,000 shares. Based on an average daily trading volume, of 865,000 shares, the days-to-cover ratio is presently 9.4 days. Currently, 42.2% of the company's stock are short sold. View Petmed Express' Current Options Chain.

Who are some of Petmed Express' key competitors?

What other stocks do shareholders of Petmed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Petmed Express investors own include Intel (INTC), Alibaba Group (BABA), AT&T (T), NVIDIA (NVDA), Netflix (NFLX), Micron Technology (MU), Ford Motor (F), Gilead Sciences (GILD), Advanced Micro Devices (AMD) and Cisco Systems (CSCO).

Who are Petmed Express' key executives?

Petmed Express' management team includes the folowing people:
  • Mr. Menderes Akdag, CEO, Pres & Director (Age 58)
  • Mr. Bruce S. Rosenbloom, CFO & Treasurer (Age 50)
  • Ms. Alison Berges, Corp. Sec. & Gen. Counsel

Who are Petmed Express' major shareholders?

Petmed Express' stock is owned by many different of institutional and retail investors. Top institutional investors include SG Americas Securities LLC (3.36%), Rothschild Investment Corp IL (0.96%), State of New Jersey Common Pension Fund D (0.76%), Inlet Private Wealth LLC (0.75%), Rhumbline Advisers (0.74%) and Scout Investments Inc. (0.61%). Company insiders that own Petmed Express stock include Frank J Formica, Gian Fulgoni, Menderes Akdag, Robert C Schweitzer and Ronald J Korn. View Institutional Ownership Trends for Petmed Express.

Which major investors are selling Petmed Express stock?

PETS stock was sold by a variety of institutional investors in the last quarter, including North Star Investment Management Corp., Nisa Investment Advisors LLC, Van Hulzen Asset Management LLC, Scout Investments Inc., Fisher Asset Management LLC, Pacer Advisors Inc., Great West Life Assurance Co. Can and Menlo Advisors LLC. View Insider Buying and Selling for Petmed Express.

Which major investors are buying Petmed Express stock?

PETS stock was purchased by a variety of institutional investors in the last quarter, including SG Americas Securities LLC, State of New Jersey Common Pension Fund D, Rhumbline Advisers, 6 Meridian, 6 Meridian, Russell Investments Group Ltd., Fox Run Management L.L.C. and Rothschild Investment Corp IL. View Insider Buying and Selling for Petmed Express.

How do I buy shares of Petmed Express?

Shares of PETS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Petmed Express' stock price today?

One share of PETS stock can currently be purchased for approximately $22.33.

How big of a company is Petmed Express?

Petmed Express has a market capitalization of $450.40 million and generates $283.42 million in revenue each year. Petmed Express employs 187 workers across the globe.View Additional Information About Petmed Express.

What is Petmed Express' official website?

The official website for Petmed Express is http://www.1800petmeds.com/.

How can I contact Petmed Express?

Petmed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The company can be reached via phone at 561-526-4444.


MarketBeat Community Rating for Petmed Express (NASDAQ PETS)

Community Ranking:  1.5 out of 5 (star half star)
Outperform Votes:  171 (Vote Outperform)
Underperform Votes:  415 (Vote Underperform)
Total Votes:  586
MarketBeat's community ratings are surveys of what our community members think about Petmed Express and other stocks. Vote "Outperform" if you believe PETS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PETS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 11/14/2019 by MarketBeat.com Staff

Featured Article: FAANG Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel